/OVATF

OVATF Stock - Ovation Science Inc.

Q: What is the analyst price target for OVATF?

Analyst price target information is not currently available for OVATF.

Q: What is OVATF's market cap?

Market capitalization information is not currently available for OVATF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.03+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.03

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for OVATF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.45

52W High$0.05

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$113,215	$61,934	$138,154	$224,949	$750,010
Gross Profit	$85,718	$54,100	$135,178	$187,995	$548,022
Gross Margin	75.7%	87.4%	97.8%	83.6%	73.1%
Operating Income	$-479,034	$-695,126	$-738,684	$-1,516,487	$-934,828
Net Income	$-456,197	$-813,149	$-794,052	$-2,393,777	$-1,184,874
Net Margin	-402.9%	-1312.9%	-574.8%	-1064.1%	-158.0%
EPS	$-0.01	$-0.03	$-0.03	$-0.08	$-0.04

Company Overview

Ovation Science Inc. engages in the production of cannabis or hemp products in Canada, the United States, and Mexico. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin care products containing hemp seed oil and cannabis under the Ovation and BASKiN brands. It offers cannabidiol infused health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and hand sanitizers under the DermSafe name. The company holds sublicenses for cannabis based products; and Lighthouse for licensed dispensaries in the United States. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Visit Website

Frequently Asked Questions about OVATF

What is OVATF's current stock price?

Ovation Science Inc. (OVATF) is currently trading at $0.03 per share. The stock has moved +0.00% today.

What is the analyst price target for OVATF?

No analyst price targets are currently available for this stock.

What sector is Ovation Science Inc. in?

Ovation Science Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is OVATF's market cap?

Ovation Science Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does OVATF pay dividends?

No, Ovation Science Inc. does not currently pay a dividend to shareholders.